- Home
- HZO vs ORIC Comparison
HZO vs ORIC Comparison
Compare HZO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HZO
- ORIC
- Stock Information
- Founded
- HZO 1998
- ORIC 2014
- Country
- HZO United States
- ORIC United States
- Employees
- HZO N/A
- ORIC N/A
- Industry
- HZO Auto & Home Supply Stores
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- HZO Consumer Discretionary
- ORIC Health Care
- Exchange
- HZO Nasdaq
- ORIC Nasdaq
- Market Cap
- HZO 450.3M
- ORIC 362.9M
- IPO Year
- HZO 1998
- ORIC 2020
- Fundamental
- Price
- HZO $27.78
- ORIC $10.50
- Analyst Decision
- HZO Strong Buy
- ORIC Strong Buy
- Analyst Count
- HZO 6
- ORIC 8
- Target Price
- HZO $36.50
- ORIC $18.83
- AVG Volume (30 Days)
- HZO 339.3K
- ORIC 1.1M
- Earning Date
- HZO 07-24-2025
- ORIC 08-11-2025
- Dividend Yield
- HZO N/A
- ORIC N/A
- EPS Growth
- HZO N/A
- ORIC N/A
- EPS
- HZO 2.44
- ORIC N/A
- Revenue
- HZO $2,420,818,000.00
- ORIC N/A
- Revenue This Year
- HZO $0.21
- ORIC N/A
- Revenue Next Year
- HZO $3.78
- ORIC N/A
- P/E Ratio
- HZO $11.38
- ORIC N/A
- Revenue Growth
- HZO N/A
- ORIC N/A
- 52 Week Low
- HZO $16.85
- ORIC $3.90
- 52 Week High
- HZO $38.20
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- HZO 68.54
- ORIC 71.20
- Support Level
- HZO $24.90
- ORIC $9.80
- Resistance Level
- HZO $26.36
- ORIC $11.19
- Average True Range (ATR)
- HZO 1.05
- ORIC 0.61
- MACD
- HZO 0.21
- ORIC -0.04
- Stochastic Oscillator
- HZO 99.77
- ORIC 83.33
About HZO MarineMax Inc. (FL)
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.